Author:
Sandvei Marie Søfteland,Vatten Lars J.,Bjelland Elisabeth Krefting,Eskild Anne,Hofvind Solveig,Ursin Giske,Opdahl Signe
Publisher
Springer Science and Business Media LLC
Reference76 articles.
1. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet. 1997;350(9084):1047–59.
2. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women’s Health Initiative Randomized Trial. JAMA. 2003;289(24):3243–53.
3. Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975–4011.
4. Moyer VA. U.S. preventive task force. medications to decrease the risk for breast cancer in women: recommendations from the U.S. preventive services task force recommendation statement. Ann Intern Med. 2013;159(10):698–708.
5. Cui Y, Deming-Halverson SL, Beeghly-Fadiel A, et al. Interactions of hormone replacement therapy, body weight, and bilateral oophorectomy in breast cancer risk. Clin Cancer Res. 2014;20(5):1169–78.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献